Status:
WITHDRAWN
Bupivacaine Versus Liposomal Bupivacaine For Breast Pain Management After Breast Recontruction
Lead Sponsor:
Case Comprehensive Cancer Center
Conditions:
Breast Cancer
Eligibility:
FEMALE
18+ years
Phase:
PHASE2
Brief Summary
The purpose of this study is to determine the most effective way to control post-operative breast pain for patients undergoing a unilateral, immediate breast reconstruction.
Detailed Description
This is a randomized controlled study to compare the effectiveness of a breast nerve block performed with bupivacaine as compared to liposomal bupivacaine in providing postsurgical analgesia in patien...
Eligibility Criteria
Inclusion
- Patients scheduled to have a unilateral, immediate breast reconstruction
Exclusion
- Pregnant
- Concurrent or recent medical condition that could interfere with study participation including:
- Hepatitis
- Alcohol/substance abuse
- Uncontrolled psychiatric disorders
- Known allergy
- Contraindication to amide-type local anesthetics, opioids, or propofol.
- Body weight of less than 50 kg
- Participated in another study involving an investigational medication within the prior 30 days
- Taking analgesics (i.e., nonsteroidal anti-inflammatory drugs, acetaminophen, or opioids), antidepressants, or glucocorticoids within the 3 days before surgery.
Key Trial Info
Start Date :
March 30 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2020
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT03393117
Start Date
March 30 2018
End Date
July 1 2020
Last Update
July 22 2020
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.